To date, however, the molecular status of the DAB2IP gene in ESCC patients treated with definitive chemoradiotherapy and the relationship between the expression of DAB2IP and chemoradiosensitivity in ESCC has not been elucidated. The gene discussed is DAB2IP; the disease is esophageal squamous cell carcinoma.